Os Therapies Inc OSTX
We take great care to ensure that the data presented and summarized in this overview for OS Therapies Inc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in OSTX
Top Purchases
Top Sells
About OSTX
Insider Transactions at OSTX
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 15
2025
|
Shalom Auerbach > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,720
-0.66%
|
$100,320
$6.74 P/Share
|
Aug 02
2024
|
Shalom Auerbach > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,743,556
+7.38%
|
-
|
Aug 02
2024
|
Shalom Auerbach > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
23,371
+50.0%
|
-
|
Aug 02
2024
|
John Ciccio Director |
BUY
Conversion of derivative security
|
Indirect |
296,570
+23.06%
|
-
|
Aug 02
2024
|
John Ciccio Director |
BUY
Conversion of derivative security
|
Indirect |
101,765
+42.22%
|
-
|
Aug 02
2024
|
Theodore F. Search Director |
BUY
Conversion of derivative security
|
Indirect |
296,570
+23.06%
|
-
|
Aug 02
2024
|
Theodore F. Search Director |
BUY
Conversion of derivative security
|
Indirect |
101,765
+42.22%
|
-
|
Last 12 Months Summary
Buy / Acquisition
2.56M
Shares
From
3
Insiders
Conversion of derivative security | 2.56M shares |
---|
Sell / Disposition
16.7K
Shares
From
1
Insiders
Open market or private sale | 16.7K shares |
---|